epirubicin has been researched along with Angiogenesis, Pathologic in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L | 1 |
| Chen, J; Huan, Y; Huang, M; Jia, Q; Ming, Y; Wang, B; Wang, J; Wang, L; Wang, T; Yao, Q; Zhang, J; Zhou, X | 1 |
| Chan, MS; Chen, SF; Chow, LW; Felizola, SJ; Ishida, T; Nemoto, N; Ohuchi, N; Sasano, H; Tamaki, K; Wang, L | 1 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
| Ju, RJ; Li, XT; Li, XY; Liu, L; Lu, WL; Shi, JF; Sun, MG; Zeng, F; Zhang, CX; Zhao, WY; Zhou, J | 1 |
| Fan, HX; Fang, H; Huang, H; Li, XS; Song, YL; Zhou, CW | 1 |
| Ju, RJ; Liu, L; Lu, WL; Mu, LM; Xie, HJ; Yan, Y; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Lee, DS; Moon, WK; Paeng, JC; Yoon, HJ | 1 |
| Hou, H; Li, T; Liu, C; Liu, D; Liu, K; Lv, H; Wang, G; Zhang, C; Zhang, X; Zhou, N; Zhu, J | 1 |
| Aguggini, S; Allevi, G; Berruti, A; Bersiga, A; Bonardi, S; Bottini, A; Brizzi, MP; Dogliotti, L; Fox, S; Generali, D; Harris, A; Mele, T; Milani, M; Volante, M | 1 |
| Adamus, R; Loose, RW; Uder, M; Wilhelm, M | 1 |
| Chen, XH; Deng, ZT; Feng, T; Geng, MY; Li, J; Li, YX; Qi, X; Song, CL; Wang, P | 1 |
| Chen, J; Huan, Y; Jia, Q; Jiang, W; Wang, L; Wei, M; Xu, J; Zheng, M | 1 |
| Bougnoux, P; Chami, L; Colas, S; Denis, F; Le Floch, O; Louisot, P; Tranquart, F | 1 |
| Bougnoux, P; Champeroux, P; Colas, S; Denis, F; Goupille, C; Hoinard, C; Mahéo, K; Tranquart, F | 1 |
| Baldan, A; Burra, P; Cardin, R; Cillo, U; Cristofori, C; Farinati, F; Giacomin, A; Girardi, L; Pivetta, G; Ragazzi, R; Sergio, A | 1 |
| Bougnoux, P; Catroux, R; de Poncheville, L; Denis, F; Prat, M; Tranquart, F | 1 |
| Aguggini, S; Allevi, G; Alquati, P; Berruti, A; Bersiga, A; Bertoli, G; Betri, E; Bolsi, G; Bottini, A; Brizzi, MP; Brunelli, A; Dogliotti, L; Generali, D; Scaratti, L | 1 |
5 trial(s) available for epirubicin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Endostatins; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Prospective Studies; Quality of Life | 2018 |
Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Perfusion Imaging; Radiography, Thoracic; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Disease-Free Survival; Drug Synergism; Epirubicin; Female; Humans; Immunohistochemistry; Italy; Kaplan-Meier Estimate; Neoplasm Staging; Neovascularization, Pathologic; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tamoxifen; Time Factors; Tissue Array Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Docetaxel; Endostatins; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Microvessels; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Radiography; Taxoids | 2013 |
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Methotrexate; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tamoxifen; Tumor Suppressor Protein p53 | 2002 |
13 other study(ies) available for epirubicin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell-Penetrating Peptides; Diosgenin; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Rats; Xenograft Model Antitumor Assays | 2020 |
Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Forkhead Transcription Factors; Humans; Immunohistochemistry; Immunophenotyping; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Neoadjuvant Therapy; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stromal Cells; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids; Tumor Microenvironment | 2014 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |
Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Drug Delivery Systems; Epirubicin; Female; HIV-1; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Pyrazoles; Sulfonamides | 2014 |
A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Endothelial Cells; Epirubicin; Glioblastoma; Glucosides; Humans; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Peptides, Cyclic; Spheroids, Cellular; Time Factors; Tissue Distribution; Xenograft Model Antitumor Assays | 2015 |
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Coordination Complexes; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Taxoids | 2016 |
Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.
Topics: Albumin-Bound Paclitaxel; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Breast; Carcinoma; Chemotherapy, Adjuvant; Circulating Tumor DNA; Cisplatin; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Female; Hand-Foot Syndrome; High-Throughput Nucleotide Sequencing; Humans; Hypertension; Lung Neoplasms; Mastectomy, Modified Radical; Middle Aged; Mutation; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Sequence Analysis, DNA; Thoracic Neoplasms; Treatment Failure; Triple Negative Breast Neoplasms | 2016 |
[Periinterventional cone-beam-CT: application at transarterial chemoembolization of liver tumors].
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media; Embolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Phantoms, Imaging; Radiation Dosage; Sensitivity and Specificity | 2011 |
Effects of the novel vascular targeting agent MDS-11P on tumor vascularity and its antitumor activity.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Endothelial Cells; Epirubicin; Humans; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Organophosphates; Oxazoles; Prodrugs; Rats; Rats, Sprague-Dawley; Tubulin | 2011 |
Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Cyclohexanes; Epirubicin; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Models, Animal; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Ultrasonography, Doppler | 2003 |
Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization.
Topics: Alkylating Agents; alpha-Tocopherol; Animals; Antibiotics, Antineoplastic; Antioxidants; Dietary Supplements; Docosahexaenoic Acids; Epirubicin; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2006 |
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Fibroblast Growth Factor 2; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Prognosis; Proportional Hazards Models; Statistics, Nonparametric; Survival Rate; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2008 |
In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours.
Topics: Animals; Antineoplastic Agents; Epirubicin; Feasibility Studies; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Models, Animal; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Ultrasonography, Doppler | 2002 |